CTT Pharmaceutical Holdings, Inc. Provides Corporate Update
July 19, 2019 16:38 ET
|
CTT Pharmaceutical Holdings, Inc.
Hamilton, Ontario, July 19, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC:CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems,...
CTT Pharmaceutical Holdings, Inc., (CTTH) Announces National Patent Applications Worldwide for Orally Administrable Nanonized Opioids, Cannabinoids, Nutraceuticals and Other Pharmaceutical Agents
January 15, 2019 08:16 ET
|
CTT Pharmaceutical Holdings, Inc.
Includes All Markets in which Aurora Cannabis Currently Operates or Contemplates Future Operations Hamilton, Ontario, Jan. 15, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc.,...
CTT Pharmaceuticals Initiates Legal Action Against Rapid Dose Therapeutics Ltd.
October 01, 2018 07:00 ET
|
CTT Pharmaceutical Holdings, Inc.
Hamilton, Ontario, Oct. 01, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings Inc. ("CTT") (OTC: CTTH) announced today that it is seeking an injunction to restrain Rapid Dose Therapeutics Ltd....
Aurora Cannabis Converts CTT Pharmaceuticals Debenture into 9% Equity Position
September 11, 2018 10:08 ET
|
CTT Pharmaceutical Holdings, Inc.
Companies Working on Regulatory Approval for CTT’s Sublingual Wafer Technology Hamilton, Ontario, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings Inc. ("CTT") (OTC: CTTH)...
CTT Pharmaceuticals Appoints Aurora Nominee Dr. Jason Dyck to Board of Directors
July 12, 2018 08:00 ET
|
CTT Pharmaceutical Holdings, Inc.
HAMILTON, Ontario, July 12, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in...
CTT Pharmaceuticals Announces Executive Management Change
June 07, 2018 07:00 ET
|
CTT Pharmaceutical Holdings, Inc.
HAMILTON, Ontario, June 07, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in...
CTT Pharmaceuticals Completes Strategic Investment with Aurora Cannabis Funds Earmarked for Expansion of Patent Portfolio
June 05, 2018 12:36 ET
|
CTT Pharmaceutical Holdings, Inc.
Hamilton, Ontario, June 05, 2018 (GLOBE NEWSWIRE) -- Further to the company’s press release of May 22, 2018, CTT Pharmaceutical Holdings Inc. ("CTT") (US-OTC: CTTH) announced today the completion...
Aurora Cannabis Makes Strategic Investment in CTT Pharmaceutical
May 22, 2018 07:31 ET
|
CTT Pharmaceutical Holdings, Inc.
Aurora Expands Exclusive Access to CTT’s Product and Development Pipeline Edmonton, AB, May 22, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB:...
CTT Pharmaceutical Holdings, Inc. Provides Corporate Update with Emphasis on Patent Portfolio
May 15, 2018 06:33 ET
|
CTT Pharmaceutical Holdings, Inc.
HAMILTON, Ontario, May 15, 2018 (GLOBE NEWSWIRE) -- HAMILTON, Ontario, May 16 2018 (GLOBE NEWSWIRE)—CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an...
UPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents
February 21, 2018 10:42 ET
|
CTT Pharmaceutical Holdings, Inc.
HAMILTON, Ontario, Feb. 21, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel drug delivery...